Myeloma Minute: Sugar and Spice

Getting Serious -and Silly- About Healthy Eating

We humans are obsessed with and confused by food. In his blog this week, IMF Chairman Dr. Brian Durie considers two recently published books that illustrate both ends of the spectrum. “I'll Have What She's Having: My Adventures in Celebrity Dieting” is a wry look at the eating habits of the fit and famous (Gwyneth Paltrow, Elizabeth Taylor, Beyoncé). “Fat Chance” is a more serious examination of the real dangers of sugar and processed foods. To read Dr. Durie’s blog, click HERE.


The FDA Approves Kyprolis (carfilzomib) Combination Therapy for Patients with Relapsed or Refractory Multiple Myeloma

The FDA announced on January 21, 2016, that Kyprolis® (carfilzomib) has been approved as a supplemental New Drug Application for use in combination with dexamethasone or with lenalidomide plus dex for treatment of multiple myeloma patients with relapsed or refractory disease; these patients must have received one or three lines of previous therapy. Also, the FDA approved Kyprolis® as a single agent for patients in the relapsed or refractory setting who have received one or more lines of therapy. To learn more, click HERE.

Boston Celtics Sink Baskets and Donations to the IMF

The International Myeloma Foundation is thrilled to announce that this NBA season, the organization’s research and education programs will be the winners in Takeda Oncology’s new campaign “3 Points for Patients.” Each time one of the 17-time champion Boston Celtics sinks a 3-point basket during the regular NBA season, Takeda Oncology will make a donation to the IMF. With the high-scoring Celtics’ track record, that could result in an additional $25,000 to support the IMF. Learn more from this video with Celtics’ Head Coach Brad Stevens.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.